Hydroxychloroquine: FDA Essentially Using Trump's Malaria Drug To Treat Coronavirus


WASHINGTON - The US Food and Drug Administration has revoked its emergency authority for the controversial malaria drug, hydroxychloroquine, promoted by President Donald Trump for the treatment of coronavirus.


The agency said in a letter that the decision was based on unwarranted new evidence that believes that "hydroxychloroquine and chloroquine may be effective in the diagnosis, treatment or prevention of COVID-19."

Quoting reports of cardiovascular problems, the FDA says patients pose a greater risk than any potential benefit.

The shipment of drugs received by the federal government from the National Stockpile is no longer distributed to state and local health authorities. On April 13, Trump announced his administration had deployed about 29 million doses of hydroxychloroquine.

The FDA warned on Monday about the interaction between antiviral drug products and remediesvir, which have been shown to have an effect against COVID-19. Remedivir Emergency Use Authorized by Gilead and delivered intravenously for the treatment of hospitalized COVID-19 patients with severe illness.

The FDA said that based on a laboratory study, it would revise its fact sheet for health care providers to say that the combination of therapies reduces the antiviral activity of remedyvir.

Hydroxychloroquine and chloroquine are still available for alternative use, so American doctors can prescribe them for COVID-19 - known as off-label prescribing.

Hydroxychloroquine is an arthritis medicine that, according to the Mayo Clinic, can be used to prevent or treat malaria in red blood cells that spread from mosquito bites. It is only available by prescription in the USA and administered in tablet form or via an intravenous drip.

List of common side effects of malaria drug status under the brand name Plaquenil, nausea, vomiting, abdominal pain or numbness, loss of appetite, weight loss, diarrhea, dizziness, spinning sensation, headache, runny nose, nervousness, and irritability. Skin rash, itching, or hair loss.

The drug stroke came to public attention in February following several short, chronic, peer-reviewed reports about hydroxychloroquine in China. There is nothing up to the classical gold standard of a double-blind, randomized, placebo-controlled trial that shows more accurately when the work is done.

On March 19, Trump talked about hydroxychloroquine given with antibiotic azithromycin. He has been with her many times in various media and public events.

Since late April, Trump has endorsed his drug stance, but during a round table discussion with restaurant officials at the White House on May 18, he said he was taking the plunge.

A study published in The Lancet at the same time by the World Health Organization announced a "temporary break" in the inclusion of drug status in a global study on possible treatment of the disease, which included survivors using COVID-19 below. The rate of life is found in drugs. Later the study was withdrawn.

The National Institute of Health Professionals revised its guidelines on Thursday to make specific recommendations against drug use, with the exception of official studies.

Post a Comment

0 Comments